Apollo Hospitals Enterprise Limited (APOLLOHOSP) Stock Forecast & Price Target

Compare

9 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

APOLLOHOSP Analyst Ratings

Moderate Buy

2 Buy

0 Hold

0 Sell

Based on 2 analysts giving stock ratings to

Apollo

Hospitals Enterprise Limited

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

APOLLOHOSP Stock 12 Month Forecast

Average Price Target

₹8,695.00

▲(22.79% Upside)

Based on 2 Wall Street analysts offering 12 month price targets for Apollo Hospitals Enterprise Limited in the last 3 months. The average price target is ₹8,695.00 with a high forecast of ₹8,840.00 and a low forecast of ₹8,550.00. The average price target represents a 22.79% change from the last price of ₹7,081.40.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6043":"₹6,043","7442":"₹7,442","8841":"₹8,841","6742.5":"₹6,742.5","8141.5":"₹8,141.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":8840,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹9K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8695,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹9K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8550,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹9K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6043,6742.5,7442,8141.5,8841],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7111.5,7244.461538461538,7377.423076923077,7510.384615384615,7643.346153846154,7776.307692307692,7909.2692307692305,8042.2307692307695,8175.192307692308,8308.153846153846,8441.115384615385,8574.076923076922,8707.038461538461,{"y":8840,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7111.5,7233.307692307692,7355.115384615385,7476.923076923077,7598.7307692307695,7720.538461538462,7842.346153846154,7964.153846153846,8085.961538461538,8207.76923076923,8329.576923076924,8451.384615384615,8573.192307692309,{"y":8695,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7111.5,7222.153846153846,7332.807692307692,7443.461538461538,7554.115384615385,7664.7692307692305,7775.423076923077,7886.076923076923,7996.7307692307695,8107.384615384615,8218.038461538461,8328.692307692309,8439.346153846154,{"y":8550,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7350.04,"date":1735689600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6796.58,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6044.26,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6621.42,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6953.15,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6904.31,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7484.62,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7334.71,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7676.95,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7442.15,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7679.55,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7287.4,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7111.5,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target₹8,840

Average Price Target₹8,695

Lowest Price Target₹8,550

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Shyam Srinivasan

Goldman Sachs

₹8,550

Buy

20.74%

Upside

Reiterated

12/07/25

Goldman Sachs Keeps Their Buy Rating on Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Abdulkader Puranwala

ICICI Securities

₹8,000→₹8,840

Buy

24.83%

Upside

Reiterated

11/07/25

Apollo Hospitals Enterprise Limited (APOLLOHOSP) Receives a Buy from ICICI Securities

Damayanti Kerai

HSBC

₹8,590→₹8,870

Buy

25.26%

Upside

Reiterated

10/09/25

Apollo Hospitals Enterprise Limited (APOLLOHOSP) Gets a Buy from HSBC

Alankar Garude

Kotak Mahindra

₹9,180→₹9,135

Buy

29.00%

Upside

Reiterated

09/15/25

Kotak Mahindra Sticks to Its Buy Rating for Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Alok Dalal

Jefferies

₹7,900→₹9,120

Buy

28.79%

Upside

Reiterated

08/13/25

Jefferies Reaffirms Their Buy Rating on Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Kunal Lakhan

CLSA

₹8,400→₹8,510

Buy

20.17%

Upside

Reiterated

07/02/25

CLSA Sticks to Its Buy Rating for Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Kunal Dhamesha

Macquarie

₹5,700

Sell

-19.51%

Downside

Reiterated

06/30/25

Macquarie Sticks to Its Sell Rating for Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Vivek Agrawal CFA

Citi

₹8,260

Buy

16.64%

Upside

Reiterated

06/30/25

Apollo Hospitals Enterprise Limited (APOLLOHOSP) Gets a Buy from Citi

Tushar Manudhane

Motilal Oswal

₹8,050

Buy

13.68%

Upside

Reiterated

05/31/25

Motilal Oswal Securities Reiterates Buy Rating on Apollo Hospitals (APHS:IN)Motilal Oswal Securities analyst Tushar Manudhane reiterated a Buy rating and INR8,050.00 price target on Apollo Hospitals (APHS:IN).

Bansi Desai

J.P. Morgan

₹8,300→₹8,800

Buy

24.27%

Upside

Reiterated

02/12/25

Apollo Hospitals (APHS:IN) PT Raised to INR8,800 at JPMorganJPMorgan analyst Bansi Desai raised the price target on Apollo Hospitals (APHS:IN) to INR8,800.00 (from INR8,300.00) while maintaining a Overweight rating.

Neha Manpuria

Bank of America Securities

₹8,225→₹8,150

Buy

15.09%

Upside

Reiterated

02/11/25

Apollo Hospitals (APHS:IN) PT Lowered to INR8,150 at BofA SecuritiesBofA Securities analyst Neha Manpuria lowered the price target on Apollo Hospitals (APHS:IN) to INR8,150.00 (from INR8,225.00) while maintaining a Buy rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Shyam Srinivasan

Goldman Sachs

₹8,550

Buy

20.74%

Upside

Reiterated

12/07/25

Goldman Sachs Keeps Their Buy Rating on Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Abdulkader Puranwala

ICICI Securities

₹8,000→₹8,840

Buy

24.83%

Upside

Reiterated

11/07/25

Apollo Hospitals Enterprise Limited (APOLLOHOSP) Receives a Buy from ICICI Securities

Damayanti Kerai

HSBC

₹8,590→₹8,870

Buy

25.26%

Upside

Reiterated

10/09/25

Apollo Hospitals Enterprise Limited (APOLLOHOSP) Gets a Buy from HSBC

Alankar Garude

Kotak Mahindra

₹9,180→₹9,135

Buy

29.00%

Upside

Reiterated

09/15/25

Kotak Mahindra Sticks to Its Buy Rating for Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Alok Dalal

Jefferies

₹7,900→₹9,120

Buy

28.79%

Upside

Reiterated

08/13/25

Jefferies Reaffirms Their Buy Rating on Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Kunal Lakhan

CLSA

₹8,400→₹8,510

Buy

20.17%

Upside

Reiterated

07/02/25

CLSA Sticks to Its Buy Rating for Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Kunal Dhamesha

Macquarie

₹5,700

Sell

-19.51%

Downside

Reiterated

06/30/25

Macquarie Sticks to Its Sell Rating for Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Vivek Agrawal CFA

Citi

₹8,260

Buy

16.64%

Upside

Reiterated

06/30/25

Apollo Hospitals Enterprise Limited (APOLLOHOSP) Gets a Buy from Citi

Tushar Manudhane

Motilal Oswal

₹8,050

Buy

13.68%

Upside

Reiterated

05/31/25

Bansi Desai

J.P. Morgan

₹8,300→₹8,800

Buy

24.27%

Upside

Reiterated

02/12/25

Neha Manpuria

Bank of America Securities

₹8,225→₹8,150

Buy

15.09%

Upside

Reiterated

02/11/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Apollo Hospitals Enterprise Limited

3 Months

xxx

Success Rate

2/2 ratings generated profit

Average Return

+7.30%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +7.30% per trade.

1 Year

Shyam SrinivasanGoldman Sachs

Success Rate

2/2 ratings generated profit

Average Return

+3.90%

reiterated a buy rating 2 months ago

Copying Shyam Srinivasan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +3.90% per trade.

2 Years

xxx

Success Rate

2/2 ratings generated profit

Average Return

+3.90%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +3.90% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

APOLLOHOSP Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, APOLLOHOSP has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. APOLLOHOSP average Analyst price target in the past 3 months is 8,695.00.

Each month's total comprises the sum of three months' worth of ratings.

APOLLOHOSP Financial Forecast

APOLLOHOSP Earnings Forecast

Next quarter’s earnings estimate for APOLLOHOSP is ₹33.84 with a range of ₹31.30 to ₹38.97. The previous quarter’s EPS was ₹33.20. APOLLOHOSP beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year APOLLOHOSP has Performed in-line its overall industry.

APOLLOHOSP Sales Forecast

Next quarter’s sales forecast for APOLLOHOSP is ₹63.34B with a range of ₹61.26B to ₹64.94B. The previous quarter’s sales results were ₹63.03B. APOLLOHOSP beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year APOLLOHOSP has Performed in-line its overall industry.

APOLLOHOSP Stock Forecast FAQ

What is IN:APOLLOHOSP’s average 12-month price target, according to analysts?

Based on analyst ratings, Apollo Hospitals Enterprise Limited’s 12-month average price target is 8,695.00.

What is IN:APOLLOHOSP’s upside potential, based on the analysts’ average price target?

Apollo Hospitals Enterprise Limited has 22.79% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Apollo Hospitals Enterprise Limited a Buy, Sell or Hold?

Apollo Hospitals Enterprise Limited has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.

What is Apollo Hospitals Enterprise Limited’s share price target?

The average share price target for Apollo Hospitals Enterprise Limited is 8,695.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹8,840.00 ,and the lowest forecast is ₹8,550.00. The average share price target represents 22.79% Increase from the current price of ₹7,081.4.

What do analysts say about Apollo Hospitals Enterprise Limited?

Apollo Hospitals Enterprise Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.

How can I buy shares of Apollo Hospitals Enterprise Limited?

To buy shares of IN:APOLLOHOSP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Apollo Hospitals Enterprise Limited (APOLLOHOSP) Stock Forecast & Price Target

APOLLOHOSP Analyst Ratings

APOLLOHOSP Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Apollo Hospitals Enterprise Limited

APOLLOHOSP Analyst Recommendation Trends

APOLLOHOSP Financial Forecast

APOLLOHOSP Earnings Forecast

APOLLOHOSP Sales Forecast

APOLLOHOSP Stock Forecast FAQ

Detailed List of Analyst Forecasts